Related Experiment Video
Updated: Jun 5, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence
David Balayssac1, Jérémy Ferrier, Juliette Descoeur
1INSERM U766, Laboratoire de Toxicologie-Faculté de Pharmacie, Place Henri Dunant, F-63000 Clermont-Ferrand, France. dbalayssac@chu-clermontferrand.fr
Introduction:
Chemotherapy-induced peripheral neuropathies (CIPN) are major dose-limiting side effects of many anticancer drugs. The incidence of CIPN varies from 10 to 100% depending on the anticancer drug. The characteristics of CIPN are related to dose intensity, cumulative dose and anticancer drug. CIPN can profoundly affect the quality-of-life, often compelling clinicians to lower the chemotherapy regimen, consequently limiting therapeutic efficacy.
Areas Covered:
Relevant literature in the field is identified through a Medline search for articles published up to August 2010 with the keywords 'neuropathy', 'anticancer drugs' and 'pain'. This study considers original papers and reviews.
Expert Opinion:
Neurotoxic anticancer drugs can affect specific peripheral nervous system structures (neuronopathy, axonopathy or myelinopathy) leading to CIPN, often with pain. Gaining deeper insights into neurotoxic mechanisms is critical to the development of new CIPN treatment and prevention strategies.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Diabetic Neuropathy
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Preclinical Development: Overview